Back to Archived Journals » Core Evidence » Volume 8 » default

Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Core Evidence

ISSN: 1555-175X


       

Archive: Volume 8, 2013

Review

Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis

Botrel TE, Paladini L, Clark OA

Core Evidence 2013, 8:69-78

Published Date: 30 September 2013

Review

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Schaller SJ, Fink H

Core Evidence 2013, 8:57-67

Published Date: 25 September 2013

Review

Lixivaptan – an evidence-based review of its clinical potential in the treatment of hyponatremia

Bowman BT, Rosner MH

Core Evidence 2013, 8:47-56

Published Date: 11 July 2013

Review

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Chavez JC, Sahakian E, Pinilla-Ibarz J

Core Evidence 2013, 8:37-45

Published Date: 16 May 2013

Review

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Golshayan AR, Antonarakis ES

Core Evidence 2013, 8:27-35

Published Date: 4 April 2013

Review

An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

Goard CA, Schimmer AD

Core Evidence 2013, 8:15-26

Published Date: 14 March 2013

Original Research

Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis

Botrel TEA, Clark O, Pompeo ACL, Bretas FFH, Sadi MV, Ferreira U, dos Reis RB

Core Evidence 2013, 8:1-13

Published Date: 7 March 2013